vaccination - The Deeping

Flu shots: how scientists around the world cooperate to choose the strains to vaccinate against each year

Dec 4, 2025

Gemma Ware, The Conversation The 40 scientists who decide which flu shot you’ll get: https://player.captivate.fm/episode/c7765a5a-8f7d-4ab2-870e-90e4b48ca3da Listen and subscribe: https://cdn.theconversation.com/infographics/561/4fbbd099d631750693d02bac632430b71b37cd5f/site/index.html Twice a year, 40 scientists gather together for five days to decide what strains of influenza to vaccinate against for the next flu season. It takes around six months to prepare the vaccine –

Mpox in the DRC: residents of the slum at the centre of Kinshasa’s epidemic have little chance of avoiding this major health crisis

Jan 31, 2025

Yap Boum, Mbarara University of Science and Technology Walking through the crowded streets of the Pakadjuma neighbourhood in Kinshasa, capital of the Democratic Republic of Congo, I am struck by the vibrant atmosphere around me. Children play happily in puddles, surrounded by piles of plastic bags and open ditches of sewage. Shacks patched

Bird flu could be eradicated by editing the genes of chickens – our study shows how

Nov 7, 2023

Alewo Idoko-Akoh, University of Bristol Recent advances in gene editing technology could potentially be used to create disease-resistant animals. This could curtail the spread of avian influenza, commonly known as bird flu. In a recent gene editing study, my colleagues and I showcased the potential of gene editing to protect chickens from the

The peril of polio control in shadow of war

Dec 19, 2022

By: Adeline Tchouakak This article was supported by Global Health Strategies. Satellite imagery and deft negotiation are critical tools for polio vaccination teams working across the world’s conflict zones, writes Adeline Tchouakak Conflict zones pose enormous challenges to those involved in polio surveillance and eradication, as security fears close off access

The genomic and clinical features of the COVID-19 Omicron variant: a narrative review

Sep 5, 2022

Coronavirus disease 2019 (COVID-19) has been a major cause of morbidity and mortality worldwide since December 2019. Up to July 2022, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 570 million people and contributed to the death of more than 6.4 million individuals around the world. Intriguingly, after more than

Effects of vaccination against COVID-19 on the emotional health of older adults

Aug 30, 2022

The COVID-19 pandemic significantly impacted the mental and emotional health of the elderly, especially those from low to middle-income countries. However, COVID-19 vaccination may reduce this influence. Therefore, we aimed to estimate the effect of vaccination against COVID-19 on the emotional health of older adults. Methods: We selected a national, random, and stratified

Effective and cheap: Cuba’s vaccines brings hope to poorer countries

Feb 14, 2022

With Abdala, Soberana 02 and Soberana Plus, Cuba has developed three highly effective protein vaccines against Covid-19. After the third vaccination, they provide 90% protection against severe symptomatic courses. Unlike mRNA and vector vaccines, protein vaccines are cheaper and easier to produce and store. Cuba’s willingness to share knowledge of vaccine development and

Vaccine passports: what businesses need to know – and why they should have more say

Jul 21, 2021

Panagiotis Balatsoukas, Loughborough University; Gyuchan Thomas Jun, Loughborough University, and Isabel Sassoon, Brunel University London Imogen, a night club owner from London, hopes that COVID-19 “passports” could help with the return of customers to her venue. But the 42-year-old told us she is not happy about subjecting her customers to additional checks, and

Some parts of the US are more vulnerable to another hit by coronavirus. Here’s why

Apr 30, 2021

After several weeks of reporting concerning Covid-19 case increases, a leading health official says the US could be starting to see a hopeful trend. The country’s seven-day average of new reported infections is going down, Centers for Disease Control and Prevention Director Dr. Rochelle Walensky said during a White House Covid-19 briefing on

South Africa to spend $712 million on mass vaccination drive

Mar 5, 2021

South Africa plans to spend $712 million to vaccinate some 67% of its 60 million people to control the country’s COVID-19 battle and get the economy to rebound from its decline of 7.2% last year. Finance Minister Tito Mboweni said the vaccination drive will help South Africa’s economy, the most developed in sub-Saharan

Login